Health & Biotech
Could these Aussie psychedelics stocks carve a slice out of a ‘potential $63 billion’ global market?
MST upgrades CardieX to 5x current share price as FDA green lights world-first vascular biometric monitor
EZZ healthy as delivers strong Q3 FY23 results including 30% rise in cash receipts and operating cash flows up by 371%
Blood Pressure Breakthrough: CardieX gets FDA green light for world-first vascular biometric monitor
ASX Health Stocks: CardieX jumps 16pc after FDA clearance; 3 other ASX biotechs to commence trials
ScoPo’s (actually Iain’s) Powerplays: ASX health stocks fall, Neuren’s DAYBUE drug officially rolling out in US
Weed Week: 420 reminds us that cannabis stocks may be down, but by no means out
PharmAust’s dog trial shows 30pc reduction in cancer tumour, increased quality of life
Argenica’s latest HIE trial results show prolonged reduction in brain injury
HealthKick Podcast: Aussie biotech Dimerix expects first data from its DMX200 Phase 3 trial by end of year
ASX Health Stocks: Control Bionics launches world’s first autonomous driving wheelchair, DROVE
Creso Pharma’s Canadian subsidiary Mernova achieves cashflow positive position and delivers record revenues
ASX Health Stocks: Neuren’s breakthrough Rett Syndrome drug DAYBUE is now officially available in the US
Incannex makes key appointment to fast-track commercialisation of key products for addiction and skin diseases
PharmAust secures more MPL tablets to safeguard supply for motor neurone disease trial
ASX Health Stocks: Osteopore licenses its bone regeneration technology; Kazia resolves problem with Nasdaq
PharmAust seeks experienced CEO to take its deep clinical trials pipeline to the next stage
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
